Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Cagrilintide for Sale > High Qulity Cagrilintide Professional Factory
High Qulity Cagrilintide Professional Factory buy - large image1
High Qulity Cagrilintide Professional Factory buy - image1
High Qulity Cagrilintide Professional Factory buy - image2
High Qulity Cagrilintide Professional Factory buy - image3
High Qulity Cagrilintide Professional Factory buy - image4
High Qulity Cagrilintide Professional Factory buy - image5

High Qulity Cagrilintide Professional Factory

59 Inquiries

Unit Price:

$100-130/G FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Food Grade

Content:

99%

Port:

QINGDAO

Brand:

SINOV

Packaging:

1Kg/Cardboard Drum

Price valid (until):

2026-08-24

Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    1.Description

    Bergenin, also known as dwarf catechin, is a needle shaped or crystalline powder extracted from the whole plant of Bergenia purpurscens   (Hook.f.et Thoms.)   Engl. in the family Saxifragaceae. Bergenin is a new variety in the 2015 Pharmacopoeia. It is mainly produced in Sichuan, Yunnan, Xizang and other places. Harvesting in spring and autumn, washing away sediment, removing decayed leaves from roots, and drying in the sun.Shop Professional Factory Supply High Qulity Bengenin-Detailed Image 1

    2.Application

    (1)Antitussive effect: Bergenin exerts its antitussive effect by inhibiting the cough center, thereby reducing the cough reflex. Its mechanism lies in selectively inhibiting the cough center without significantly enhancing the inhibition of other central nervous system functions, which is different from opioid-based central antitussive drugs.

    (2)Antibacterial: It can effectively inhibit the growth of various bacteria, including Staphylococcus aureus, Escherichia coli, Shigella, and Pseudomonas aeruginosa. It primarily achieves its antibacterial effect by blocking bacterial cell wall synthesis and disrupting their living environment.

    (3)Anti-inflammatory: Bergenin is capable of reducing the production of inflammatory mediators, thereby lowering the inflammatory response of tissues.

    (4)Antitumor effect: Bergenin exhibits significant inhibitory effects on certain types of tumor cells, such as gastric cancer, liver cancer, and lung cancer. It achieves its antitumor effect by inducing tumor cell apoptosis and inhibiting tumor cell proliferation, while simultaneously enhancing the body's immune function and improving its ability to combat tumors.

    3.Application fields

    (1)Pharmaceutical Field:

    Clinical Applications: Bergenin is primarily used in the treatment of respiratory diseases such as chronic bronchitis, emphysema, pulmonary heart disease, bronchial asthma, and others. Its pharmacological effects include antitussive, expectorant, anti-inflammatory, and antibacterial properties.

    Mechanism of Action: It alleviates cough symptoms by inhibiting the cough center in the central nervous system and reducing the sensitivity of the cough reflex. It promotes the discharge of respiratory mucosal secretions to help clear phlegm. It also alleviates pain and discomfort caused by respiratory inflammation by reducing the inflammation.

    (2)Health Supplement Field:

    Health Benefits: Bergenin has potential health benefits such as enhancing immunity and improving metabolism, which can be utilized in the development of health supplements.

    Market Applications: As a component in health supplements, Bergenin can be used to prevent or alleviate respiratory diseases and improve overall health.

    (3)Cosmetic Field:

    Skincare Efficacy: Bergenin has antioxidant, whitening, acne-clearing, and anti-inflammatory effects, which can be applied in cosmetic development.

    Product Examples: Cosmetics containing Bergenin can be used to reduce skin pigmentation, remove spots and freckles, and improve skin condition.

    4. Packing & Shipping

    Generally, the Bergenin  will be packed in two plastic bags and one foil bag, and then a fiber drum for 25kg.

    Shop Professional Factory Supply High Qulity Bengenin-Detailed Image 2

    Shop Cosmetic Raw Materials Hyaluronic Acid Powder-Detailed Image 2

    Items Specifications
    Origin China
    Purity

    5%-99%

    Appearance Powder
    Color White
    Package

    Drum, Plastic Container, Vacuum Packed

    Shelf life

    2 years

    Storage

    Cool Dry Place

    ECHEMI Editorial Reference
    Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. This drug is an investigational therapy that reduced body weight in a phase 2 trial when administered as monotherapy in participants without diabetes and with a BMI of at least 30 kg/m2 or at least 27 kg/m2 with hypertension or dyslipidaemia[1-2].

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Inquiry History
    59 Inquiries
    Country Product Purchase Quantity Date Posted
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.